These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 36872359)

  • 1. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
    Liang W; Wang C; Wang J; Zhang M
    Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
    Shin WS; Hong Y; Lee HW; Lee ST
    Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma.
    Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T
    Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
    Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
    Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics and network pharmacology identify promotional effects and potential mechanisms of ethanol on esophageal squamous cell carcinoma and experimental validation.
    Huang M; Wu Z; Jia L; Wang Y; Gao S; Liu Y; Zhang Y; Li J
    Toxicol Appl Pharmacol; 2023 Sep; 474():116615. PubMed ID: 37406968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-
    Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
    Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
    Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
    World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
    Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
    Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.
    Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N
    Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
    Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
    Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
    Zhang GJ; Zhao J; Jiang ML; Zhang LC
    Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels.
    Chen S; Lin X; He R; Zhang W; Kang M; Xu R
    Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of target genes and potential mechanisms related to compound Xiao-ai-fei honey ointment based on network pharmacology and bioinformatics analysis.
    Abudurousuli K; Talihati Z; Hailati S; Han MY; Nuer M; Khan N; Maihemuti N; Dilimulati D; Nueraihemaiti N; Simayi J; Zhou W
    Medicine (Baltimore); 2023 Aug; 102(32):e34629. PubMed ID: 37565919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAPI-1 Exhibits Anti-tumor Efficacy in Human Esophageal Squamous Cell Carcinoma Cells via Suppression of NF-κB Signaling Pathway.
    Gao L; Li L; Zhang D; Qiu J; Qian J; Liu H
    Dig Dis Sci; 2024 Jan; 69(1):81-94. PubMed ID: 38007701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Neddylation Inhibition on Inflammation-Induced MMP9 Gene Expression in Esophageal Squamous Cell Carcinoma.
    Hryniewicz-Jankowska A; Wierzbicki J; Tabola R; Stach K; Sossey-Alaoui K; Augoff K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells.
    Ma H; Ma X; Qi L; Zhang Q; Wang T; Guo Q; Li P; Zhang S; Liu S
    J Gene Med; 2024 Jun; 26(6):e3708. PubMed ID: 38837511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.
    Dilly AK; Ekambaram P; Guo Y; Cai Y; Tucker SC; Fridman R; Kandouz M; Honn KV
    Int J Cancer; 2013 Oct; 133(8):1784-91. PubMed ID: 23526143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
    Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
    Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.